Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
334.85
0.00 (0.00%)
Oct 3, 2024, 8:31 AM EST - Market open
Bio-Rad Laboratories Market Cap
Bio-Rad Laboratories has a market cap or net worth of $9.12 billion as of November 21, 2024. Its market cap has increased by 4.59% in one year.
Market Cap
9.12B
Enterprise Value
8.88B
1-Year Change
4.59%
Ranking
Category
Stock Price
$334.85
Market Cap Chart
Since November 21, 2019, Bio-Rad Laboratories's market cap has decreased from $10.78B to $9.12B, a decrease of -15.40%. That is a compound annual growth rate of -3.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 9.17B | -1.39% |
| Dec 29, 2023 | 9.30B | -25.52% |
| Dec 30, 2022 | 12.48B | -44.81% |
| Dec 31, 2021 | 22.62B | 30.09% |
| Dec 31, 2020 | 17.39B | 57.32% |
| Dec 31, 2019 | 11.05B | 2.52% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Henry Schein | 9.19B |
| Penumbra | 9.18B |
| Tempus AI | 9.16B |
| Intra-Cellular Therapies | 9.08B |
| Bio-Rad Laboratories | 9.06B |
| HealthEquity | 8.99B |
| Masimo | 8.83B |
| Teleflex | 8.70B |